[The impact of the HPV test in screening programs in Latin America: The case of Argentina]

Salud Publica Mex. 2019 Ene-Feb;61(1):86-94. doi: 10.21149/9257.
[Article in Spanish]

Abstract

Objective: To assess the impact of HPV testing on longstanding problems faced by screening programs in Latin America, using the case of the Jujuy Demonstration Project (JDP) in Argentina.

Materials and methods: . The study measured the level of impact produced by the introduction of HPV-testing on problems faced by cytology programs by analyzing modifications on specific problems produced during the JDP. Impact was classified as direct/indirect, and positive/negative.

Results: Direct/positive impact was found in issues concerning age and screening frequency,cytology laboratories and screening sensitivity, and low coverage. Direct/negative impact was mainly related to the adherence to triage cytology by HPV+ women with self-collected-tests, and the delivery and labelling of samples. Indirect impact of HPV-Test was mostly positive, and related to the programmatic reorganization which was facilitated by the introduction of HPV testing.

Conclusions: HPV testing provides an opportunity window for improving primary screening, but does not solve programmatic problems.

Objetivo: Evaluar el impacto de la prueba deVPH (prueba de VPH) en los problemas que históricamente afectaron al tamizaje de cáncer cervical en América Latina, tomando como caso al Proyecto Demostración para la Introducción de la prueba deVPH en Jujuy (PDJ),Argentina.

Material y métodos: Se sintetizó la evidencia sobre los problemas del tamizaje cervical en la región. Se analizó el impacto en los problemas a partir de la introducción de la prueba de VPH. El impacto se clasificó en directo/indirecto y positivo/negativo.

Resultados: El impacto directo-positivo se dio en los problemas de adherencia a la edad/frecuencia de ta- mizaje, laboratorios de citología, baja/moderada sensibilidad de la citología y baja cobertura. El impacto directo-negativo se vinculó con el triaje de autotoma y el envío/etiquetado de muestras. El impacto indirecto-positivo se relacionó con la reorganización programática realizada para introducir la prueba de VPH.

Conclusiones: La prueba de VPH representa una ventana de oportunidad para el mejoramiento del tamizaje pero no resuelve los problemas programáticos.

Keywords: cervical cancer prevention programs; cytology; health evaluation; mass screening; papillomavirus infection.

MeSH terms

  • Argentina / epidemiology
  • Data Collection
  • Developing Countries
  • Female
  • Guideline Adherence
  • Human Papillomavirus DNA Tests*
  • Humans
  • Mass Screening / methods
  • Mass Screening / organization & administration
  • Mass Screening / statistics & numerical data*
  • Papillomavirus Infections / diagnosis*
  • Papillomavirus Infections / epidemiology
  • Patient Acceptance of Health Care
  • Precancerous Conditions / diagnosis
  • Precancerous Conditions / epidemiology
  • Program Evaluation
  • Social Determinants of Health
  • Social Problems
  • Uterine Cervical Neoplasms / prevention & control*
  • Vaginal Smears*